Loading clinical trials...
Loading clinical trials...
A Phase I, Randomized Study of the Safety and Efficacy of Intravenous Delivery of Lung Spheroid Stem Cells (LSCs) in Patients With Idiopathic Pulmonary Fibrosis
Conditions
Interventions
Lung Spheroid Stem Cells 100 million
Lung Spheroid Stem Cells 200 million
Locations
1
United States
University of North Carolina as Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
October 22, 2020
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
January 29, 2026
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions